239 related articles for article (PubMed ID: 35197475)
21. Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.
Johnson DB; Peng C; Abramson RG; Ye F; Zhao S; Wolchok JD; Sosman JA; Carvajal RD; Ariyan CE
Oncologist; 2015 Jun; 20(6):648-52. PubMed ID: 25964307
[TBL] [Abstract][Full Text] [Related]
22. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.
Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS
Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations in primary melanoma in Taiwan.
Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
[TBL] [Abstract][Full Text] [Related]
24. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
25. Expression of soluble adenylyl cyclase in acral melanomas.
Li H; Kim SM; Savkovic V; Jin SA; Choi YD; Yun SJ
Clin Exp Dermatol; 2016 Jun; 41(4):425-9. PubMed ID: 26290224
[TBL] [Abstract][Full Text] [Related]
26. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
[TBL] [Abstract][Full Text] [Related]
27. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
29. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
30. [Somatic Mutations Associated with Metastasis in Acral Melanoma].
Abramov IS; Emelyanova MA; Ryabaya OO; Krasnov GS; Zasedatelev AS; Nasedkina TV
Mol Biol (Mosk); 2019; 53(4):648-653. PubMed ID: 31397438
[TBL] [Abstract][Full Text] [Related]
31. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
32. Early acral melanoma in situ: correlation between the parallel ridge pattern on dermoscopy and microscopic features.
Ishihara Y; Saida T; Miyazaki A; Koga H; Taniguchi A; Tsuchida T; Toyama M; Ohara K
Am J Dermatopathol; 2006 Feb; 28(1):21-7. PubMed ID: 16456320
[TBL] [Abstract][Full Text] [Related]
33. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
34. Author Correction: Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
Farshidfar F; Rhrissorrakrai K; Levovitz C; Peng C; Knight J; Bacchiocchi A; Su J; Yin M; Sznol M; Ariyan S; Clune J; Olino K; Parida L; Nikolaus J; Zhang M; Zhao S; Wang Y; Huang G; Wan M; Li X; Cao J; Yan Q; Chen X; Newman AM; Halaban R
Nat Commun; 2022 May; 13(1):2704. PubMed ID: 35538087
[No Abstract] [Full Text] [Related]
35. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Garraway LA; Widlund HR; Rubin MA; Getz G; Berger AJ; Ramaswamy S; Beroukhim R; Milner DA; Granter SR; Du J; Lee C; Wagner SN; Li C; Golub TR; Rimm DL; Meyerson ML; Fisher DE; Sellers WR
Nature; 2005 Jul; 436(7047):117-22. PubMed ID: 16001072
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
Vazquez Vde L; Vicente AL; Carloni A; Berardinelli G; Soares P; Scapulatempo C; Martinho O; Reis RM
Melanoma Res; 2016 Apr; 26(2):93-9. PubMed ID: 26709572
[TBL] [Abstract][Full Text] [Related]
37. Early detection of acral melanoma: A review of clinical, dermoscopic, histopathologic, and molecular characteristics.
Darmawan CC; Jo G; Montenegro SE; Kwak Y; Cheol L; Cho KH; Mun JH
J Am Acad Dermatol; 2019 Sep; 81(3):805-812. PubMed ID: 30731177
[TBL] [Abstract][Full Text] [Related]
38. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
Thielmann CM; Chorti E; Matull J; Murali R; Zaremba A; Lodde G; Jansen P; Richter L; Kretz J; Möller I; Sucker A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Paschen A; Livingstone E; Zimmer L; Schadendorf D; Hadaschik E; Ugurel S; Griewank KG
Eur J Cancer; 2021 Dec; 159():113-124. PubMed ID: 34742158
[TBL] [Abstract][Full Text] [Related]
39. Differences by Anatomical Site of Non-Acral Lentiginous Melanomas of the Lower Limb.
Gavillero A; García-Casado Z; Requena C; Manrique-Silva E; Traves V; Kumar R; Nagore E
Dermatology; 2022; 238(5):977-985. PubMed ID: 35350018
[TBL] [Abstract][Full Text] [Related]
40. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]